BLT2 antagonist-1
Modify Date: 2024-01-09 16:12:12
BLT2 antagonist-1 structure
|
Common Name | BLT2 antagonist-1 | ||
|---|---|---|---|---|
| CAS Number | 2069220-61-5 | Molecular Weight | 435.49 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H26FNO4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BLT2 antagonist-1BLT2 antagonist-1 (compound 15b) is a selective BLT2 antagonist that inhibits the chemotaxis of CHO-BLT2 cells with an IC50 of 224 nM. BLT2 antagonist-1 does not inhibits the chemotaxis of CHO-BLT1 cells. BLT2 antagonist-1 also inhibits the binding of LTB4 and BLT2 with a Ki value of 132 nM. BLT2 antagonist-1 can be used for the research of the inflammatory airway diseases such as asthma and chronic obstructive pulmonary disease[1]. |
| Name | BLT2 antagonist-1 |
|---|
| Description | BLT2 antagonist-1 (compound 15b) is a selective BLT2 antagonist that inhibits the chemotaxis of CHO-BLT2 cells with an IC50 of 224 nM. BLT2 antagonist-1 does not inhibits the chemotaxis of CHO-BLT1 cells. BLT2 antagonist-1 also inhibits the binding of LTB4 and BLT2 with a Ki value of 132 nM. BLT2 antagonist-1 can be used for the research of the inflammatory airway diseases such as asthma and chronic obstructive pulmonary disease[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H26FNO4 |
|---|---|
| Molecular Weight | 435.49 |